Kahn Brothers GroupSuperinvestor
About Kahn Brothers Group’s 13F portfolio
Kahn Brothers Group is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Kahn Brothers Group reported $632.7M across 48 US-listed positions (). Its largest position is Citigroup Inc (C) at 19% of the reported book, and its ten biggest holdings make up 79% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NYSE: C Citigroup Inc | $115.28 −1.76% | 19% | 836K | $117.1M |
| 2 | — Bayer AG Spons ADR | — — | 14% | 6.5M | $89.3M |
| 3 | NYSE: FLG Flagstar Financial, Inc. | $10.03 −2.24% | 9.6% | 4.1M | $60.9M |
| 4 | NASDAQ: GOOG Alphabet Inc Class C | $271.02 −2.93% | 6.8% | 121K | $42.7M |
| 5 | NASDAQ: Z Zillow Group Inc | $27.29 −3.19% | 5.9% | 1.2M | $37.3M |
| 6 | NYSE: OGN Organon & Co | $13.91 −0.07% | 5.7% | 2.7M | $36.2M |
| 7 | NYSE: DIS Walt Disney | $120.25 −1.72% | 5.5% | 359K | $34.6M |
| 8 | NYSE: MRK Merck & Co. Inc. | $132.81 −3.61% | 4.4% | 218K | $28.0M |
| 9 | NYSE: MBI M B I A Inc | $4.37 −2.24% | 4.3% | 4.2M | $27.5M |
| 10 | NYSE American: SEG Seaport Entmt Group | $20.50 +1.99% | 3.9% | 917K | $24.4M |
| 11 | NYSE American: SEB Seaboard Corp | $3,684.49 −0.45% | 3.8% | 5K | $24.1M |
| 12 | OTC: BPAQF BP PLC | $7.21 −3.03% | 3.7% | 625K | $23.1M |
| 13 | NYSE: IDT IDT Corp Class B | $74.89 −2.14% | 3.2% | 352K | $20.5M |
| 14 | NASDAQ: PTEN Patterson Uti Energy | $9.72 +0.10% | 2.4% | 1.7M | $15.3M |
| 15 | NYSE: PFE Pfizer | $27.54 −1.85% | 1.8% | 464K | $11.2M |
| 16 | NYSE: BMY Bristol-Myers Squibb | $58.34 −2.05% | 1.6% | 174K | $10.0M |
| 17 | NYSE: GSK GSK PLC ADR | $47.82 −1.56% | 1.3% | 158K | $8.3M |
| 18 | NYSE: XOM ExxonMobil | $158.93 −1.03% | 0.4% | 18K | $2.4M |
| 19 | NYSE: GNE Genie Energy LTD Class B | $18.48 −1.28% | 0.3% | 152K | $2.2M |
| 20 | OTC: NVSEF Novartis AG | $156.50 −1.85% | 0.3% | 13K | $2.1M |
| 21 | OTC: FRFHF Fairfax Finl HLDGS LTD Sub VTG | $1,866.63 −0.34% | 0.3% | 1K | $1.7M |
| 22 | NASDAQ: CSX CSX Corp Com | $49.98 −2.63% | 0.3% | 35K | $1.7M |
| 23 | — First Natl BK Alaska | — — | 0.2% | 5K | $1.6M |
| 24 | OTC: TRMLF Tourmaline Oil Corp Com | $43.73 −1.06% | 0.2% | 27K | $1.1M |
| 25 | NYSE: JPM JPMorgan Chase | $320.22 −1.20% | 0.1% | 3K | $942K |
Showing 1–25 of 48 positions on this page reported in this 13F.
- Financial Services33%
- Communication Services21%
- Healthcare15%
- Industrials4.1%
- Real Estate3.9%
- Energy2.9%
- Utilities0.4%
- Technology0.3%
- Consumer Defensive0.1%
- Added—Bayer AG Spons ADR+0.1%$89.3M
- AddedZZillow Group Inc+117%$37.3M
- AddedMBIM B I A Inc+105%$27.5M
- AddedSEGSeaport Entmt Group+2.7%$24.4M
- AddedBPAQFBP PLC+0.4%$23.1M
- AddedBMYBristol-Myers Squibb+2.2%$10.0M
- AddedJPMJPMorgan Chase+2.1%$942K
- AddedMSFTMicrosoft+3.6%$809K
- AddedHLNHaleon PLC+3.4%$544K
- AddedRFLRafael Holdings Inc Class B+157%$494K
- ReducedCCitigroup Inc−0.5%$117.1M
- ReducedFLGFlagstar Financial, Inc.−0.2%$60.9M
- ReducedGOOGAlphabet Inc Class C−0.9%$42.7M
- ReducedOGNOrganon & Co−51.8%$36.2M
- ReducedDISWalt Disney−5.2%$34.6M
- ReducedMRKMerck & Co. Inc.−4.0%$28.0M
- ReducedSEBSeaboard Corp−8.2%$24.1M
- ReducedIDTIDT Corp Class B−5.6%$20.5M
- ReducedPTENPatterson Uti Energy−1.6%$15.3M
- ReducedPFEPfizer−4.3%$11.2M
Reading Kahn Brothers Group’s 13F portfolio
Kahn Brothers Group’s $632.7M 13F book is spread across 48 reported positions and is highly concentrated — its ten largest positions alone are 79% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are C, Bayer AG Spons ADR, FLG, GOOG and Z, led by Citigroup Inc (C) at 19% of the portfolio. The heaviest sector exposure is Financial Services (33%), then Communication Services (21%).
What Kahn Brothers Group changed last quarter
Between 2026-03-31 and Q2 2026, Kahn Brothers Group was a net seller: it opened 1 new positions and added to 12 more, while trimming 16 and closing 1 outright. Against a 48-name book, that is low turnover, pointing to gradual, incremental repositioning rather than a wholesale change of view. Its largest new or increased position was Bayer AG Spons ADR, and its biggest reduction was Citigroup Inc (C).
What a 13F does and doesn’t reveal
A 13F captures only Kahn Brothers Group’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Kahn Brothers Group is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Kahn Brothers Group's profile on this page is built directly from those filings.
How current is the 13F data on Kahn Brothers Group's page?
It reflects Kahn Brothers Group's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Kahn Brothers Group files its next quarterly report, this page refreshes automatically.
Can I see Kahn Brothers Group's complete list of holdings?
This page highlights Kahn Brothers Group's largest positions rather than all 48 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Kahn Brothers Group's filings.
Does a 13F show everything Kahn Brothers Group owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Kahn Brothers Group's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Kahn Brothers Group made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.


